JPM vs CME
By Alex · Tickerpine
JPMorgan Chase & Co. vs CME Group Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JPM | CME |
|---|---|---|
| Price | $331.58 | $305.71 |
| Market cap | $880.54B | $109.93B |
| P/E ratio | 13.9 | 25.1 |
| ROE | 18.01% | 16.13% |
| Profit margin | 34.59% | 63.46% |
| Revenue growth | 10.20% | 13.20% |
| Dividend yield | 1.99% | 1.70% |
| Beta | 1.01 | 0.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JPM vs CME in plain English
- JPM is the bigger company — about 8.0× the market cap of CME.
- JPM is cheaper on earnings (P/E 13.9 vs 25.1).
- JPM earns a higher return on equity (18% vs 16%).
- CME is growing revenue faster (13% vs 10%).
- JPM has the higher dividend yield (1.99% vs 1.70%).
How would $1,000 have done in each?
JPM return calculator
See what $1,000 in JPMorgan Chase & Co. would be worth today.
CME return calculator
See what $1,000 in CME Group Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.